In vivo, it has been shown that the expressions of IL-37 were up-regulated by inflammatory activity and pro-inflammatory cytokines in autoimmune diseases, such as rheumatoid arthritis and SLE, especially in active stage of autoimmune disease [25], [34]. This evidence concerns the gene IL37 and systemic lupus erythematosus.